JP2017531448A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017531448A5 JP2017531448A5 JP2017537016A JP2017537016A JP2017531448A5 JP 2017531448 A5 JP2017531448 A5 JP 2017531448A5 JP 2017537016 A JP2017537016 A JP 2017537016A JP 2017537016 A JP2017537016 A JP 2017537016A JP 2017531448 A5 JP2017531448 A5 JP 2017531448A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cells
- motif
- ligand
- fibronectin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1459539A FR3026744B1 (fr) | 2014-10-06 | 2014-10-06 | Methode de generation de progeniteurs de cellules t |
| FR1459539 | 2014-10-06 | ||
| PCT/EP2015/072889 WO2016055396A1 (fr) | 2014-10-06 | 2015-10-05 | Méthode de génération de progéniteurs de cellules t |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020209370A Division JP2021072779A (ja) | 2014-10-06 | 2020-12-17 | Ｔ細胞前駆細胞を生成するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017531448A JP2017531448A (ja) | 2017-10-26 |
| JP2017531448A5 true JP2017531448A5 (enExample) | 2018-11-15 |
| JP6898240B2 JP6898240B2 (ja) | 2021-07-07 |
Family
ID=52102849
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017537016A Active JP6898240B2 (ja) | 2014-10-06 | 2015-10-05 | Ｔ細胞前駆細胞を生成するための方法 |
| JP2020209370A Pending JP2021072779A (ja) | 2014-10-06 | 2020-12-17 | Ｔ細胞前駆細胞を生成するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020209370A Pending JP2021072779A (ja) | 2014-10-06 | 2020-12-17 | Ｔ細胞前駆細胞を生成するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12071635B2 (enExample) |
| EP (2) | EP3204492B1 (enExample) |
| JP (2) | JP6898240B2 (enExample) |
| CA (1) | CA2963756C (enExample) |
| DK (1) | DK3204492T3 (enExample) |
| ES (1) | ES2914082T3 (enExample) |
| FR (1) | FR3026744B1 (enExample) |
| HU (1) | HUE059468T2 (enExample) |
| PL (1) | PL3204492T3 (enExample) |
| PT (1) | PT3204492T (enExample) |
| WO (1) | WO2016055396A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12076342B2 (en) | 2016-04-08 | 2024-09-03 | The Governing Council Of The University Of Toronto | Method for generating progenitor t cells from stem and/or progenitor cells and use of same |
| ES2931530T3 (es) * | 2017-02-13 | 2022-12-30 | Hopitaux Paris Assist Publique | Método para generar progenitores de células T |
| CA3091158A1 (en) | 2018-02-14 | 2019-08-22 | Sunnybrook Research Institute | Method for generating cells of the t cell lineage |
| FR3079239A1 (fr) * | 2018-03-23 | 2019-09-27 | Centre National De La Recherche Scientifique | Nouvelle methode d’obtention de cellules t a partir de cellules souches pluripotentes, et leurs utilisations |
| CA3096812A1 (en) * | 2018-04-10 | 2019-10-17 | Stichting Sanquin Bloedvoorziening | Chimeric notch receptors |
| CN116615461A (zh) | 2020-11-30 | 2023-08-18 | 醣基生医股份有限公司 | 用于富集细胞的抗体 |
| US20260152721A1 (en) | 2021-11-04 | 2026-06-04 | Aphp (Assistance Publique - Hôpitaux De Paris) | Method for generating nk cells |
| KR20250152088A (ko) | 2023-02-22 | 2025-10-22 | 메이라지티엑스 셀 테라피스 | 흉선 재생 방법 |
| WO2025012449A1 (en) * | 2023-07-12 | 2025-01-16 | Smart Immune | Biobank of cellular banks having specific homozygous hla haplotypes and uses thereof for treating patients |
| WO2025219552A1 (en) | 2024-04-17 | 2025-10-23 | Assitance Publique Hopitaux De Paris | Method for producing t cell progenitors from human pluripotent stem cells |
| WO2025255678A1 (en) * | 2024-06-14 | 2025-12-18 | Stemcell Technologies Canada Inc. | Compositions and methods for generating lymphoid lineage cells |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6093531A (en) | 1997-09-29 | 2000-07-25 | Neurospheres Holdings Ltd. | Generation of hematopoietic cells from multipotent neural stem cells |
| WO1999028486A1 (en) | 1997-12-04 | 1999-06-10 | Duke University | Methods of isolating and using cd7+cd34-lin-hematopoietic cells |
| EP1666589B1 (en) * | 2003-08-22 | 2010-02-17 | Takara Bio Inc. | Process for producing cytotoxic lymphocytes |
| US10059923B2 (en) | 2008-01-30 | 2018-08-28 | Memorial Sloan Kettering Cancer Center | Methods for off-the-shelf tumor immunotherapy using allogeneic T-cell precursors |
| CA2737193A1 (en) | 2008-09-12 | 2010-03-18 | Universidade Federal De Sao Paulo - Unifesp | Ischemic tissue cell therapy |
| US8772028B2 (en) | 2008-11-07 | 2014-07-08 | Sunnybrook Health Sciences Centre | CD34+CD7+CD5+CD1a-human progenitor T-cells produced in vitro and methods of using |
| US8871510B2 (en) * | 2009-12-03 | 2014-10-28 | University Of Utah Research Foundation | Methods for generating T lymphocytes from hematopoietic stem cells |
| EP3590520B1 (en) | 2010-04-09 | 2021-12-29 | Fred Hutchinson Cancer Research Center | Compositions for providing hematopoietic function without hla matching |
| WO2013074916A1 (en) | 2011-11-18 | 2013-05-23 | Board Of Regents, The University Of Texas System | Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla |
| WO2013086436A1 (en) | 2011-12-08 | 2013-06-13 | Fred Hutchinson Cancer Research Center | Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells |
| US20150352180A1 (en) * | 2013-01-11 | 2015-12-10 | The Trustee Of The University Of Pennsylvania | Notch Ligand Bound Biocompatible Substrates And Their Use In Bone Formation |
| EP3027755B1 (en) | 2013-08-02 | 2019-10-09 | The Regents of The University of California | Engineering antiviral t cell immunity through stem cells and chimeric antigen receptors |
| US20170128556A1 (en) | 2013-12-26 | 2017-05-11 | Thyas Co. Ltd. | Immunotherapy using t precursor cells derived from pluripotent stem cells having rearranged t cell receptor genes |
| US20170158749A1 (en) | 2014-04-23 | 2017-06-08 | Board Of Regents, The University Of Texas System | Chimeric antigen receptors (car) and methods for making and using the same |
| JP6661544B2 (ja) | 2014-04-24 | 2020-03-11 | ミルテニイ バイオテック ゲゼルシャフト ミット ベシュレンクテル ハフツング | 遺伝子改変したｔ細胞の自動生成法 |
| WO2016039933A1 (en) * | 2014-09-11 | 2016-03-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Lentiviral vector for treating hemoglobin disorders |
-
2014
- 2014-10-06 FR FR1459539A patent/FR3026744B1/fr active Active
-
2015
- 2015-10-05 CA CA2963756A patent/CA2963756C/fr active Active
- 2015-10-05 HU HUE15771979A patent/HUE059468T2/hu unknown
- 2015-10-05 EP EP15771979.0A patent/EP3204492B1/fr active Active
- 2015-10-05 JP JP2017537016A patent/JP6898240B2/ja active Active
- 2015-10-05 PT PT157719790T patent/PT3204492T/pt unknown
- 2015-10-05 US US15/516,731 patent/US12071635B2/en active Active
- 2015-10-05 PL PL15771979.0T patent/PL3204492T3/pl unknown
- 2015-10-05 DK DK15771979.0T patent/DK3204492T3/da active
- 2015-10-05 EP EP22152734.4A patent/EP4036224A1/fr not_active Withdrawn
- 2015-10-05 ES ES15771979T patent/ES2914082T3/es active Active
- 2015-10-05 WO PCT/EP2015/072889 patent/WO2016055396A1/fr not_active Ceased
-
2020
- 2020-12-17 JP JP2020209370A patent/JP2021072779A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107922925B (zh) | 用于自然杀伤细胞扩增的方法 | |
| Netsrithong et al. | Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation | |
| ES2931530T3 (es) | Método para generar progenitores de células T | |
| JP6898240B2 (ja) | Ｔ細胞前駆細胞を生成するための方法 | |
| CA2954534C (en) | Manufacture and cryopreservation of fucosylated cells for therapeutic use | |
| JP6775426B2 (ja) | 臍帯血由来のプールｎｋ細胞並びにがん及び慢性感染症の治療のためのこれらの用途 | |
| Alidadi et al. | Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects | |
| Brauer et al. | T cell genesis: in vitro veritas est? | |
| Netsrithong et al. | Advances in adoptive cell therapy using induced pluripotent stem cell-derived T cells | |
| IL277467B1 (en) | Method for producing natural killer cells | |
| JP2023522326A (ja) | 条件付き不死化に関する制御可能な導入遺伝子を含む人工多能性細胞 | |
| US20200263136A1 (en) | Methods of preparing hematopoietic progenitor cells in vitro | |
| CN114621920A (zh) | 一种由造血干祖细胞向nk细胞分化的方法及培养基 | |
| Jiang et al. | Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges | |
| JP7743980B2 (ja) | ヒトＴ細胞由来ｉＰＳ細胞由来の細胞傷害性Ｔ細胞 | |
| Mehra et al. | The emerging role of induced pluripotent stem cells as adoptive cellular immunotherapeutics | |
| Better et al. | 287. Production of KTE-C19 (Anti-CD19 CAR T Cells) for ZUMA-1: a Phase 1/2 Multi-Center Study evaluating safety and efficacy in subjects with refractory aggressive Non-Hodgkin Lymphoma (NHL) | |
| JP2025533901A (ja) | グローバル、民族、又は疾患特異的集団をカバーするための同種異系細胞療法のための免疫適合性細胞 | |
| Ren et al. | Umbilical cord blood hematopoietic stem cell expansion ex vivo | |
| Lisini et al. | Stem cell production: Processes, practices, and regulation: Stem cell culture and expansion: Role of culture, types of cells, growth conditions, media nutrients, growth factors, growth phase cycle | |
| JPWO2008056734A1 (ja) | ヒト胚性幹細胞からの樹状細胞の製造方法 | |
| Lisini et al. | Stem Cell Production: Processes, Practices, and Regulation | |
| Chen et al. | Advances and Challenges in the Ex Vivo Production of Megakaryocytes and Platelets | |
| Stockland et al. | BRIDGING RESEARCH AND CLINICAL PRACTICE OF ADVANCE OFF-THE-SHELF ALLOGENEIC NATURAL KILLER CELL THERAPY | |
| Cantore et al. | 286. Genome Editing of Inducible Cell Lines for Scalable Production of Improved Lentiviral Vectors for Human Gene Therapy |